INTRODUCTION: Preeclampsia and other placental pathologies are characterized by a lack of spiral artery remodeling associated with insufficient invasion by extravillous trophoblast cells (EVT). Because trophoblast invasion occurs in early pregnancy when access to human placental tissue is limited, there is a need for model systems for the study of trophoblast differentiation and invasion. Human embryonic stem cells (hESC) treated with BMP4- differentiate to trophoblast, and express HLA-G, a marker of EVT. The goals of the present study were to further characterize the HLA-G(+) cells derived from BMP4-treated hESC, and determine their suitability as a model. METHODS: HESC were treated with BMP4 under 4% or 20% oxygen and tested in Matrigel invasion chambers. Both BMP4-treated hESC and primary human placental cells were separated into HLA-G(+) and HLA-G(-)/TACSTD2(+) populations with immunomagnetic beads and expression profiles analyzed by microarray. RESULTS: There was a 10-fold increase in invasion when hESC were BMP4-treated. There was also an independent, stimulatory effect of oxygen on this process. Invasive cells expressed trophoblast marker KRT7, and the majority were also HLA-G(+). Gene expression profiles revealed that HLA-G(+), BMP4-treated hESC were similar to, but distinct from, HLA-G(+) cells isolated from first trimester placentas. Whereas HLA-G(+) and HLA-G(-) cells from first trimester placentas had highly divergent gene expression profiles, HLA-G(+) and HLA-G(-) cells from BMP4-treated hESC had somewhat similar profiles, and both expressed genes characteristic of early trophoblast development. CONCLUSIONS: We conclude that hESC treated with BMP4 provide a model for studying transition to the EVT lineage.
INTRODUCTION:Preeclampsia and other placental pathologies are characterized by a lack of spiral artery remodeling associated with insufficient invasion by extravillous trophoblast cells (EVT). Because trophoblast invasion occurs in early pregnancy when access to human placental tissue is limited, there is a need for model systems for the study of trophoblast differentiation and invasion. Human embryonic stem cells (hESC) treated with BMP4- differentiate to trophoblast, and express HLA-G, a marker of EVT. The goals of the present study were to further characterize the HLA-G(+) cells derived from BMP4-treated hESC, and determine their suitability as a model. METHODS: HESC were treated with BMP4 under 4% or 20% oxygen and tested in Matrigel invasion chambers. Both BMP4-treated hESC and primary human placental cells were separated into HLA-G(+) and HLA-G(-)/TACSTD2(+) populations with immunomagnetic beads and expression profiles analyzed by microarray. RESULTS: There was a 10-fold increase in invasion when hESC were BMP4-treated. There was also an independent, stimulatory effect of oxygen on this process. Invasive cells expressed trophoblast marker KRT7, and the majority were also HLA-G(+). Gene expression profiles revealed that HLA-G(+), BMP4-treated hESC were similar to, but distinct from, HLA-G(+) cells isolated from first trimester placentas. Whereas HLA-G(+) and HLA-G(-) cells from first trimester placentas had highly divergent gene expression profiles, HLA-G(+) and HLA-G(-) cells from BMP4-treated hESC had somewhat similar profiles, and both expressed genes characteristic of early trophoblast development. CONCLUSIONS: We conclude that hESC treated with BMP4 provide a model for studying transition to the EVT lineage.
Authors: Bernhard Ugele; Marie V St-Pierre; Monika Pihusch; Andrew Bahn; Peer Hantschmann Journal: Am J Physiol Endocrinol Metab Date: 2002-10-29 Impact factor: 4.310
Authors: Hui Chen Feng; Mei Yee Choy; Wen Deng; Hing Lok Wong; Wui Man Lau; Annie N Y Cheung; Hextan Y S Ngan; Sai Wah Tsao Journal: J Soc Gynecol Investig Date: 2005-05
Authors: L C Giudice; C A Conover; L Bale; G H Faessen; K Ilg; I Sun; B Imani; L-F Suen; J C Irwin; M Christiansen; M T Overgaard; C Oxvig Journal: J Clin Endocrinol Metab Date: 2002-05 Impact factor: 5.958
Authors: Richard Vasicek; Gudrun Meinhardt; Eva Haidweger; Hans Rotheneder; Peter Husslein; Martin Knöfler Journal: Gene Date: 2003-01-02 Impact factor: 3.688
Authors: Ying Yang; Katsuyuki Adachi; Megan A Sheridan; Andrei P Alexenko; Danny J Schust; Laura C Schulz; Toshihiko Ezashi; R Michael Roberts Journal: Proc Natl Acad Sci U S A Date: 2015-04-13 Impact factor: 11.205
Authors: Rowan M Karvas; Samuel McInturf; Jie Zhou; Toshihiko Ezashi; Danny J Schust; R Michael Roberts; Laura C Schulz Journal: Mol Hum Reprod Date: 2020-06-01 Impact factor: 4.025
Authors: Shinichiro Yabe; Andrei P Alexenko; Mitsuyoshi Amita; Ying Yang; Danny J Schust; Yoel Sadovsky; Toshihiko Ezashi; R Michael Roberts Journal: Proc Natl Acad Sci U S A Date: 2016-04-05 Impact factor: 11.205
Authors: Prasenjit Sarkar; Shan M Randall; Timothy S Collier; Anthony Nero; Teal A Russell; David C Muddiman; Balaji M Rao Journal: J Biol Chem Date: 2015-02-10 Impact factor: 5.157
Authors: Arun S Seetharam; Ha T H Vu; Sehee Choi; Teka Khan; Megan A Sheridan; Toshihiko Ezashi; R Michael Roberts; Geetu Tuteja Journal: Stem Cell Reports Date: 2022-05-19 Impact factor: 7.294
Authors: Tamara Tilburgs; Ângela C Crespo; Anita van der Zwan; Basya Rybalov; Towfique Raj; Barbara Stranger; Lucy Gardner; Ashley Moffett; Jack L Strominger Journal: Proc Natl Acad Sci U S A Date: 2015-05-26 Impact factor: 11.205
Authors: J Zhou; R C West; E L Ehlers; T Ezashi; L C Schulz; R M Roberts; Y Yuan; D J Schust Journal: Biol Reprod Date: 2021-07-02 Impact factor: 4.285